Informação sobre produto
- trans-Dihydrodehydrodiconiferyl alcohol 4′-O-α-L-rhamnopyranoside
- α-L-Mannopyranoside, 4-[(2R,3S)-2,3-dihydro-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2-benzofuranyl]-2-methoxyphenyl 6-deoxy-
- Dihydrodehydrodiconiferyl alcohol 9′-O-α-L-rhamnoside
- 4-[(2R,3S)-2,3-Dihydro-3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2-benzofuranyl]-2-methoxyphenyl 6-deoxy-α-L-mannopyranoside
Icariside E4 is an indirubin analog that has been shown to have potent anticancer properties. It acts as an inhibitor of protein kinases, which are enzymes that play a crucial role in cancer cell growth and survival. Icariside E4 induces apoptosis, or programmed cell death, in tumor cells by targeting specific signaling pathways involved in cancer development. This compound has been isolated from Chinese herbal medicine and has shown activity against a variety of human cancers, including breast, lung, and prostate cancer. Additionally, Icariside E4 has been detected in urine samples from healthy individuals, indicating its potential use as a biomarker for cancer diagnosis and treatment monitoring. Overall, Icariside E4 represents a promising new class of anticancer agents with significant therapeutic potential.
Propriedades químicas
Consulta técnica sobre: 3D-BFA25342 Icariside E4
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
